Affordable Access

Access to the full text

Antihypertensive Drugs and Diabetic Retinopathy in Patients with Type 2 Diabetes

Authors
  • Lin, Jen-Chieh
  • Lai, Mei-Shu
Type
Published Article
Journal
Ophthalmologica
Publisher
S. Karger AG
Publication Date
Dec 23, 2015
Volume
235
Issue
2
Pages
87–96
Identifiers
DOI: 10.1159/000441958
PMID: 26695432
Source
Karger
Keywords
License
Green
External links

Abstract

Objective: To evaluate the association between the development of sight-threatening diabetic retinopathy (STDR) and antihypertensive drugs (AHDs) use among type 2 diabetic patients with concomitant hypertension. Methods: Type 2 diabetic patients aged 20-100 years who had at least one prescription for AHDs between 2000 and 2011 were identified from the Longitudinal Health Insurance Database (LHID) 2005. The incidence rates of STDR were followed and Cox proportional hazard models were used to analyze the risk associated with AHDs. Results: Users of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) were associated with a significantly higher risk than users of calcium channel blockers (CCBs), independent of baseline characteristics. After adjusting for time-varying use of concomitant medications for propensity score-matched or -unmatched cohorts, the results showed that patients receiving ACEIs/ARBs and CCBs were associated with a significantly greater risk compared with β-blocker users. Conclusions: Our study did not support a superiority of ACEIs/ARBs and CCBs over β-blockers for lowering the progression of diabetic retinopathy.

Report this publication

Statistics

Seen <100 times